TMCnet News
Research and Markets: United States Infectious Disease Molecular Diagnostics Market 2015-2019: Emerging Opportunities and Growth Strategies for SuppliersResearch and Markets (http://www.researchandmarkets.com/research/76gjbs/20152019_us) has announced the addition of the "2015-2019 US Infectious Disease Molecular Diagnostics Market: Emerging Opportunities and Growth Strategies for Suppliers--Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. This new study contains 1,013 pages, 62 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporae strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent (News - Alert) Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/76gjbs/20152019_us.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150804006141/en/ |
